Spots Global Cancer Trial Database for Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
Official Title: A Phase II Trial of Reduced Intensity Fludarabine and Total Body Irradiation-Based Conditioning Prior to Haplo-Identical Transplantation for Patients With Hematologic Malignancies
Study ID: NCT05417971
Conditions
Interventions
Study Description
Brief Summary: This trial will evaluate the safety and efficacy of RIC HIDT transplant protocol following fludarabine and intermediate-dose TBI 800 cGy utilizing PBSC as the stem cell source.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Caitlin Guzowski, Atlanta, Georgia, United States
Contact Details
Name: Scott Solomon, MD
Affiliation: BMTGA
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
